Isoniazid API is a first-line antitubercular agent used in the treatment and prevention of tuberculosis, inhibiting mycolic acid synthesis in Mycobacterium tuberculosis.

Isoniazid API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.